CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS

Clinical trial NCT07612774 · RECRUITING

Trial details

NCT number: NCT07612774
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Coronary Artery Disease

Start date: 2026-05-19
Primary completion: 2028-12-31
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.